Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Yu

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Stem Cell Research & Therapy|February 28, 2020
The necessity for standardization of glioma stem cell culture: a systematic reviewLei Zhang, Hongwei Yu, Yuhui Yuan, et al.
Cancer Research|July 17, 2004
HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cellsGentao Liu, Han Ying, Gang Zeng, et al.
Scientific Reports|January 5, 2023
Activated T cell therapy targeting glioblastoma cancer stem cellsKen Miyaguchi, Hongqiang Wang, Keith L Black, et al.
Neurosurgical Focus|May 20, 2006
Brain tumor stem cells: new targets for clinical treatments?Patrizia Tunici, Dwain Irvin, Gentao Liu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2003
Intratumoral dendritic cell vaccination elicits potent tumoricidal immunity against malignant glioma in ratsMoneeb Ehtesham, Peter Kabos, Mervin A R Gutierrez, et al.
Cancer Research|July 17, 2004
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant gliomaJohn S Yu, Gentao Liu, Han Ying, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2004
Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing gliomaYasuharu Akasaki, Gentao Liu, Nancy H C Chung, et al.
Expert Opinion on Biological Therapy|January 17, 2007
Immunomodulatory neural stem cells for brain tumour therapyJeffrey J Yu, Xiaonan Sun, Xiangpeng Yuan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant gliomaGentao Liu, Hung T Khong, Christopher J Wheeler, et al.
Surgical Neurology|July 17, 2003
Development of an intracranial ependymoma at the site of a pre-existing cavernous malformationMoneeb Ehtesham, Peter Kabos, William H Yong, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Stem Cell Research & Therapy|February 28, 2020
The necessity for standardization of glioma stem cell culture: a systematic reviewLei Zhang, Hongwei Yu, Yuhui Yuan, et al.
Cancer Research|July 17, 2004
HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cellsGentao Liu, Han Ying, Gang Zeng, et al.
Scientific Reports|January 5, 2023
Activated T cell therapy targeting glioblastoma cancer stem cellsKen Miyaguchi, Hongqiang Wang, Keith L Black, et al.
Neurosurgical Focus|May 20, 2006
Brain tumor stem cells: new targets for clinical treatments?Patrizia Tunici, Dwain Irvin, Gentao Liu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2003
Intratumoral dendritic cell vaccination elicits potent tumoricidal immunity against malignant glioma in ratsMoneeb Ehtesham, Peter Kabos, Mervin A R Gutierrez, et al.
Cancer Research|July 17, 2004
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant gliomaJohn S Yu, Gentao Liu, Han Ying, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2004
Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing gliomaYasuharu Akasaki, Gentao Liu, Nancy H C Chung, et al.
Expert Opinion on Biological Therapy|January 17, 2007
Immunomodulatory neural stem cells for brain tumour therapyJeffrey J Yu, Xiaonan Sun, Xiangpeng Yuan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant gliomaGentao Liu, Hung T Khong, Christopher J Wheeler, et al.
Surgical Neurology|July 17, 2003
Development of an intracranial ependymoma at the site of a pre-existing cavernous malformationMoneeb Ehtesham, Peter Kabos, William H Yong, et al.
Pageof 10